Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Consensus Definitions & Up-to-Date Management

In this post, we emphasize the critical need for nontuberculous mycobacteria (NTM) and fungal testing for patients undergoing CAR T-cell therapy. While this innovative treatment has shown effectiveness against certain cancers, it significantly suppresses the immune system, making patients more vulnerable to opportunistic infections...

Watch the on-demand webinar where we’ll explore the significance of TTV in clinical settings and its potential as an objective aid for modifying immunosuppression in transplant recipients. Discover the latest diagnostic tools and methodologies that utilize TTV, along with real-world examples showcasing its impact on patient outcomes. The session will also include an interactive Q&A. Don’t miss this opportunity to enhance your understanding of TTV in transplant care!

Explore our NTM abstract poster on "Development and Validation of a Suite of Multiplexed PCR Assays for the Detection and Differentiation of Non-Tuberculous Mycobacteria."

Join us for an insightful webinar featuring Dr. Stella Davies, a distinguished pediatric hematologist-oncologist from Cincinnati Children's. In this presentation, Dr. Davies will delve into the complexities of Thrombotic Microangiopathy (TA-TMA), exploring its underlying causes and implications. With over 20 years of experience, Dr. Davies offers a comprehensive look at the latest research and clinical perspectives on this critical condition. Don't miss this opportunity to gain valuable knowledge from a leading expert in the field.

This post discusses the clinical significance of Torque Teno Virus (TTV) as a biomarker for transplant patients. TTV monitoring helps assess immune function, particularly for solid organ and stem cell transplant recipients, by indicating infection risk and potential organ rejection. Higher TTV loads suggest a greater risk of infection, while lower levels signal a higher chance of rejection. TTV levels can also aid in managing immunosuppression and predicting adverse events in CAR T-cell therapy​.

Join us for an insightful presentation by Dr. Luis Ostrosky-Zeichner, MD, where we explore the latest advancements and emerging trends in the field of medical mycology. The discussion covers critical topics such as current epidemiological data, evolving nomenclature standards, and recent innovations in antifungal treatments. Additionally, the video delves into the necessity for new diagnostic methods to keep pace with novel drugs and examines the evolving practices in clinical trial conduct. Join us for a comprehensive update on where medical mycology stands today and what the future holds.

This post discusses the growing potential of Torque Teno Virus (TTV) testing as a tool for monitoring patient immune status, particularly for those who are immunocompromised, like organ transplant recipients. TTV is prevalent in most adults but is not directly linked to specific diseases. Its significance lies in its use as a marker of immune function, helping clinicians assess infection risks and transplant rejection by monitoring viral loads. This type of testing is especially valuable in guiding treatment decisions for patients with compromised immune systems​.

At Eurofins Viracor, our Fighting Fungals brochure highlights our robust fungal testing menu, differential testing capabilities, and commitment to delivering faster results to aid in anti-fungal therapy monitoring. We understand the critical nature of invasive fungal diseases (IFDs), particularly among immunocompromised patients such as organ transplant recipients, HIV/AIDS patients, and those battling cancer. Our advanced diagnostics enable early detection and precise treatment strategies, empowering healthcare providers...

Northwestern Abstract Poster - Association of Under Immunosuppression as Defined by Torque Teno Viral Load and Clinical Outcomes in Kidney Transplant Recipients